Allied Biotech Corporation (1780.TWO)

TWD 16.9

(0.0%)

EBITDA Summary of Allied Biotech Corporation

  • Allied Biotech Corporation's latest annual EBITDA in 2023 was 204.79 Million TWD , down -24.3% from previous year.
  • Allied Biotech Corporation's latest quarterly EBITDA in 2024 Q2 was 37.66 Million TWD , down 0.0% from previous quarter.
  • Allied Biotech Corporation reported an annual EBITDA of 270.54 Million TWD in 2022, up 187.62% from previous year.
  • Allied Biotech Corporation reported an annual EBITDA of 94.06 Million TWD in 2021, down -45.73% from previous year.
  • Allied Biotech Corporation reported a quarterly EBITDA of 37.66 Million TWD for 2024 Q1, up 10.09% from previous quarter.
  • Allied Biotech Corporation reported a quarterly EBITDA of 34.21 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Allied Biotech Corporation (2023 - 2019)

Historical Annual EBITDA of Allied Biotech Corporation (2023 - 2019)

Year EBITDA EBITDA Growth
2023 204.79 Million TWD -24.3%
2022 270.54 Million TWD 187.62%
2021 94.06 Million TWD -45.73%
2020 173.32 Million TWD 0.0%
2019 199.13 Million TWD 0.0%

Peer EBITDA Comparison of Allied Biotech Corporation

Name EBITDA EBITDA Difference
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 11.382%
Easywell Biomedicals, Inc. -85.5 Million TWD 339.52%
TTY Biopharm Company Limited 1.52 Billion TWD 86.566%
Synmosa Biopharma Corporation 1 Billion TWD 79.698%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 64.869%
Center Laboratories, Inc. -175.17 Million TWD 216.91%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -559.598%
Orient Pharma Co., Ltd. 172.39 Million TWD -18.792%
InnoPharmax Inc. -62.12 Million TWD 429.672%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -61.663%
Excelsior Biopharma Inc. -29.36 Million TWD 797.307%
DV Biomed Co., Ltd. 407.64 Million TWD 49.762%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 122.451%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 74.49%
UniPharma Co., Ltd. -16.25 Million TWD 1359.948%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -55.961%
Alar Pharmaceuticals Inc. 394.52 Million TWD 48.091%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 10.307%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 624.65%
Bioray Biotech Co., Ltd 12.13 Million TWD -1587.614%
TSH Biopharm Corporation Limited 99.35 Million TWD -106.132%